CORRECTION OF IMMUNOSUPRESSION IN CANCER PATIENTS DEPENDING ON THE TYPE OF ANESTHESIA
Keywords:
immunosuppression, immunocorrection, immunity, anesthesiaAbstract
The conducted comparative assessment of the effectiveness of the proposed treatment and diagnostic algorithm for the correction of perioperative immunosuppression in cancer patients showed its high clinical effectiveness. The use of immunocorrection before surgery provided a significant improvement in the indices of both cellular and humoral immune responses, with a limitation of the severity of the inflammatory cascade, a decrease in the level of proinflammatory cytokines and stabilization of the activity of regulatory links.
Downloads
References
1. Belyaev A. M., Baldueva I. A., Prokhorov G. G., et al. Immunological changes in patients with malignant neoplasms after cryogenic and ultrasound ablation of the tumor // Issues of oncology. - 2017. - Vol. 63, No. 1. - P. 14-18. - EDN YHPYWH.
2. Veter E. V., Ermukhanova A. E., Togaeva D. K., Serikbek D. K. Immunotherapy in oncology: innovative strategies, clinical efficacy and prospects for personalized treatment. Review // Epomen: medical sciences. - 2025. - No. 19. - P. 6-31. – EDN PPHZBH
3. Zagidullina E. R., Zdorov G. S., Korsunskaya A. I., et al. Immune-mediated adverse reactions during therapy with immune checkpoint inhibitors // Medicine. Sociology. Philosophy. Applied research. – 2025. – No. 2. – P. 53–57. – EDN APQMAY
4. Protsenko S. A. Immunotherapy of lung cancer // Effective pharmacotherapy. – 2019. – Vol. 15, No. 24. – P. 48–58. – EDN FUXDOG
5. Aboalsoud A., El-Ghaiesh S. H., Elmonem F. F. A., et al. The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response // Int Immunopharmacol. – 2020. – Vol. 78. – Article 106068. – DOI: 10.1016/j.intimp.2019.106068
6. Al-Mozain N., Arora S., Goel R., et al. Patient blood management in adults and children: What have we achieved, and what still needs to be addressed? // Transfus Clin Biol. – 2023. – Vol. 30. – P. 355–359. – DOI: 10.1016/j.tracli.2023.03.005.
7. Bezu L., Chuang A.W., Sauvat A., et al. Local anesthetics elicit-dependent anticancer effects // J. Immunother. Cancer. – 2022. – Vol. 10. – e004151. – DOI: 10.1136/jitc-2021-004151
8. Carnet Le Provost K., Kepp O., Kroemer G., et al. Trial watch: beta-blockers in cancer therapy // Oncoimmunology. – 2023. – Vol. 12, No. 1. – Article 2284486. – DOI: 10.1080/2162402X.2023.2284486
9. Gu L., Pan X., Wang C., et al. The benefits of propofol on cancer treatment: Decipher its modulation code to immunocytes // Front Pharmacol. – 2022. – Vol. 13. – Article 919636. – DOI: 10.3389/fphar.2022.919636.
